Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of COVID-19 vaccines and booster regimens in elderly and COPD patients
TCTR20210822002Recruiting
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- Jun 2021
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Viral Vector Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Trial of ChAdOx1 nCoV-19 and coronavac in coronavirus disease 2019 (COVID-19), sponsored by Faculty of Medicine, Chiang Mai University. Primary endpoint: Immunogenicity against SARS-CoV-2 variants of concern. Started Jun 2021; status: recruiting.
02
Drugs
ChAdOx1 nCoV-19coronavac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20210822002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210822002.